673. The Immune Compromised Hostís Ability to Respond to Vaccines
Session: Symposium: Vaccinating the Immunocompromised Host
Friday, October 19, 2012: 10:30 AM
Room: SDCC 33 ABC
Steven Holland, MD, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD

Dr. Steven M. Holland received his BA from St. Johnís College in Annapolis Maryland, and his MD from Johns Hopkins University School of Medicine in Baltimore in 1983. He stayed at Hopkins as an intern, resident, and chief resident in internal medicine, followed by a fellowship in infectious diseases. He came to the NIAID in 1989 to study the molecular biology of HIV, and in 1991 moved to the Laboratory of Host Defenses, NIAID, to study phagocytes and phagocyte immunodeficiencies. In 2004 he became Chief, Laboratory of Clinical Infectious Diseases, NIAID. In 2011 he was named the Deputy Director for Intramural Clinical Research for the NIH. His work centers on understanding the pathophysiology and treatment of infections in patients with congenital and acquired immune defects affecting the phagocytes.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.